ASSOCIATION OF BASELINE IL-23 PATHWAY-ASSOCIATED GENE EXPRESSION WITH RISANKIZUMAB-INDUCED CLINICAL REMISSION AND ENDOSCOPIC RESPONSE AT WEEK 12 IN CROHN’S DISEASE PATIENTS

James O. Lindsay  ¹     Valerie Pivorunas  ²     Naim Al Mahi     Nizar Smaoui     F. Stephen Laroux     Bram Verstockt  ³     Kristina Kligys     Kori Wallace     Heath M. Guay     Jean-Frédéric Colombel  ^4    
1 Queen Mary University of London, London, United Kingdom
² AbbVie, Inc, North Chicago, United States
³ University Hospitals Leuven and KU Leuven, Translational Research in Gastrointestinal Disorders - IB, Leuven, Belgium
⁴ Icahn School of Medicine at Mount Sinai, USA, United States

Topic
Endoscopy, IBD

Session
IL-23-Blockers in IBD: Part 1

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)